Last Update 12 Jun 26
Fair value Decreased 3.13%ITECH: Extended EU Approval And Strong Margins Will Support Future Upside
Analysts have reduced their price target on I-Tech from SEK 112.0 to SEK 108.5 after incorporating updated assumptions for revenue growth, profit margins, discount rate, and future P/E into their models.
What's in the News
- The European Commission and the Standing Committee on Biocidal Products extended EU approval for I-Tech's antifouling biocide Selektope (medetomidine) for use in antifouling coatings (product-type 21) until 31 December 2026, citing delays in the ongoing assessment for reasons outside the company’s control. (Source: Key Developments)
- The extension maintains regulatory continuity for Selektope and its customers during the remaining EU review period, with the substance having been approved for use in antifouling coatings in the EU since 2016. (Source: Key Developments)
- I-Tech has raised concerns about parts of the Selektope re-approval process, including how alternatives are assessed and how available scientific data is interpreted, and has stressed the importance of decisions based on complete and up to date evidence. (Source: Key Developments)
- The company is funding a new Extended One-Generation Reproductive Toxicity study on Selektope to generate additional data on safe use and possible endocrine effects, primarily for use outside the EU but also expected to be relevant for European regulators. (Source: Key Developments)
- I-Tech describes this investment as part of a long term commitment to product stewardship, transparency and evidence based regulation for Selektope. (Source: Key Developments)
Valuation Changes
- Fair Value: SEK 112.0 to SEK 108.5, a small downward adjustment in the modeled estimate.
- Discount Rate: 5.48% to 5.42%, a slight reduction in the rate used to discount future cash flows.
- Revenue Growth: 17.11% to 21.29%, a higher assumed growth rate for future SEK revenues.
- Net Profit Margin: 30.74% to 32.45%, a modest uplift in the projected profitability on SEK earnings.
- Future P/E: 19.00x to 14.73x, a lower multiple applied to expected earnings in the updated valuation work.
Key Takeaways
- Strengthening regulatory environment and expanding global approvals are set to boost demand for I-Tech's eco-friendly antifouling technology and open new markets.
- Product innovation, recurring revenues, and operational efficiencies are expected to drive margin improvement and support long-term growth.
- Dependence on a key product, regulatory risks, regional concentration, and currency volatility threaten revenue stability and earnings growth despite margin improvements.
Catalysts
About I-Tech- A biotechnology company, develops, markets, and sells antifouling coating products in Sweden.
- Adoption of sustainable marine chemicals is accelerating due to tightening environmental regulations and the need to curb invasive species spread, directly supporting future demand for I-Tech's eco-friendly Selektope technology and expanding its addressable market-likely driving long-term revenue growth.
- The ongoing expansion of Selektope's regulatory approvals, including progress on EU reregistration and anticipated moves into markets like the U.S., positions I-Tech to unlock new regions for product sales-catalyzing additional revenue streams.
- Delivery of new ships is projected to increase by 9% this year, indicating continuing growth in the global maritime fleet and sustained demand for advanced antifouling solutions, which supports I-Tech's core business and underpins future earnings growth.
- Advancements in next-generation antifouling products discussed by management, including new technical milestones with potential for significant market impact, could enhance product differentiation and support higher margins over time.
- Rising recurring revenue from a broadening customer base, combined with improved gross margins from supply chain optimization and process improvements, is likely to provide better earnings visibility and support stronger operating margins moving forward.
I-Tech Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming I-Tech's revenue will grow by 21.3% annually over the next 3 years.
- Analysts assume that profit margins will increase from 21.2% today to 32.5% in 3 years time.
- Analysts expect earnings to reach SEK 94.9 million (and earnings per share of SEK 6.75) by about June 2029, up from SEK 34.8 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 16.1x on those 2029 earnings, down from 23.8x today. This future PE is lower than the current PE for the SE Chemicals industry at 22.9x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 5.42%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Ongoing regulatory uncertainty in the EU related to Selektope's reregistration process poses a significant risk; delays or unfavorable outcomes could restrict access to key markets, negatively impacting future revenue and overall earnings.
- Heavy dependence on a limited number of core products, particularly Selektope, makes I-Tech vulnerable to technological substitution or patent expiries, which could undermine long-term revenue stability and reduce earnings visibility.
- I-Tech's customer concentration in Asia (99% RSA in Asia) and shifting sales dynamics (e.g., drop in China, increased share in Korea) expose the company to regional trade turbulence, competitive pressures, and policy risks, potentially impacting both revenue growth and net margins.
- Despite gross margin improvements, currency headwinds (e.g., 13% loss on exchange rates in Q2) and ongoing exposure to FX volatility may erode net margins and cause unpredictable fluctuations in reported earnings.
- Market turbulence and a slowdown in new vessel contracting, if prolonged, could dampen long-term demand for antifouling coatings, potentially leading to uneven revenue streams and compressing future earnings growth.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of SEK108.5 for I-Tech based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of SEK140.0, and the most bearish reporting a price target of just SEK77.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be SEK292.5 million, earnings will come to SEK94.9 million, and it would be trading on a PE ratio of 16.1x, assuming you use a discount rate of 5.4%.
- Given the current share price of SEK69.0, the analyst price target of SEK108.5 is 36.4% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on I-Tech?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.